| Name | 11beta,17-dihydroxypregna-1,4-diene-3,20-dione 17-propionate |
|---|---|
| Synonyms | RD20000 |
| Description | RD20000 is a corticosteroid which is obtained by esterifying with propionic acid the 17-position of the prednisolone skeleton and deoxidating its 21-position. |
|---|---|
| Related Catalog | |
| In Vitro | RD20000 (Deprodone propionate) as an effective ingredient, can exhibit its effects to the maximum extent and over a prolonged period of time, do not have skin irritation, and are physicochemically stable. RD20000 can be maintained in a stably suspended state owing to the thickening action of the suspending agent[1]. |
| References |
| Density | 1.2 g/cm3 |
|---|---|
| Boiling Point | 540.6ºC at 760 mmHg |
| Molecular Formula | C24H32O5 |
| Molecular Weight | 400.50800 |
| Flash Point | 180.9ºC |
| Exact Mass | 400.22500 |
| PSA | 80.67000 |
| LogP | 3.54610 |
| Vapour Pressure | 6.07E-14mmHg at 25°C |
| Index of Refraction | 1.566 |